sabcs2014: analysis of the soft trial: prudence francis
Published 9 years ago • 798 plays • Length 19:27Download video MP4
Download video MP3
Similar videos
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
11:55
sabcs2014: progression-free survival results from bolero-1 trial
-
2:14
dr. francis discusses the soft trial for breast cancer
-
16:55
sabcs2014 2
-
24:33
session 9: adjuvant endocrine therapy for premenopausal women: risk stratification, type & duration
-
0:58
dr. francis on the benefits of ovarian suppression for younger women
-
3:42
hormone therapy for breast cancer and the side effects of tamoxifen
-
8:49
sabcs 2022: results from the phase iii capitello-291 trial
-
33:06
single-cell variability underlying cancer therapy resistance | sydney shaffer | scp2020
-
13:12
sabcs2014: 16 year long-term follow-up of the ibis-i breast cancer prevention trial
-
4:59
sabcs2014 - ingo bauerfeind zum ibcsg soft trial
-
1:14
dr. francis on ovarian suppression for younger women with hr breast cancer
-
1:09
dr. rao on the soft trial in patients with premenopausal breast cancer
-
7:12
determining benefit of ovarian function suppression: soft trial
-
7:26
s1222 hr , stage iv breast cancer: fulvestrant w/wo everolimus /- anastrozole
-
1:40
dr. francis on ovarian suppression in young women with breast cancer
-
1:32
dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
-
53:09
efl001 - confirmatory testing in primary aldosteronism
-
2:21
phase iii extenet trial at the 2020 sabcs
-
3:37
comparing adjuvant tamoxifen with ovarian function suppression via exomestane to tamoxifen alone
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results